| Literature DB >> 22956923 |
Girts Murans1, Bengt Gustavsson, Helena Saraste.
Abstract
STUDYEntities:
Year: 2010 PMID: 22956923 PMCID: PMC3427964 DOI: 10.1055/s-0030-1267063
Source DB: PubMed Journal: Evid Based Spine Care J ISSN: 1663-7976
Fig 1Demographic and baseline characteristics of groups.
Demographic and baseline characteristics of groups
| Total study group n = 136 | H1 n = 64 | H2 n = 72 | |
|---|---|---|---|
| Age in years | 12.1 ± 5.5 | 11.5 ± 6.8 | 12.7 ± 4 |
| Female, n (%) | 68 (50) | 27 (42.2) | 41 (56.9) |
| Number of fused segments | 12.9 ± 3.6 | 12.9 ± 4.2 | 12.9 ± 2.9 |
| Full ambulators | 20 (14.7) | 10 (15.6) | 10 (13.9) |
| Ambulators with neurological disease | 10 (7.4) | 4 (6.3) | 6 (8.3) |
| Ambulator with crutches and/or orthotics | 20 (14.7) | 6 (9.4) | 14 (19.4) |
| Wheelchair bound | 86 (63.2) | 44 (68.8) | 42 (58.3) |
| Curve size (Cobb) | 59.14 ± 29.1 | 59.8° ± 32.2 | 58.5° ± 26.1 |
| MMC | 29 (21.3) | 17 (26.6) | 12 (16.7) |
| CP | 29 (21.3) | 15 (23.4) | 14 (19.4) |
| Duchenne | 6 (4.4) | 1 (1.6) | 5 (6.9) |
| SMA | 12 (8.8) | 5 (7.8) | 7 (9.7) |
| Neuroendocrine | 12 (8.8) | 6 (9.4) | 6 (8.3) |
| Tumor related | 29 (21.3) | 11 (17.2) | 18 (25.0) |
| Congenital | 19 (14) | 9 (14.1) | 10 (13.9) |
| Anterior procedures, n (%) | 89 (65.4) | 44 (68.8) | 45 (62.5) |
| Neurosurgical intervention, n (%) | 34 (25) | 19 (29.7) | 15 (20.8) |
MMC = meningomyelocel
CP = cerebral palsy
SMA = spinal muscular atrophy
Neuroendocrine = syndromes such as Rett syndrome.
Radiographic variables, mean (±SD) for H1 and H2 before and after surgery, at follow-up, and average correction
| Before surgery | After surgery | After surgery Mean correction % | Follow-up | Follow-up Mean correction % | Loss of correction in degrees | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| H1 | H2 | H1 | H2 | H1 | H2 | H1 | H2 | H1 | H2 | ||||
| Cobb | 60 (±32) | 58 (±26) | 20 (±19) | 30 (±20) | 66 | 50 | < .001 | 23 (±21) | 30 (±20) | 59 | 47 | .01 | 2.1 |
| Rotation | 28 (±22) | 25 (±17) | 13 (±13) | 15 (±12) | 48 | 33 | .01 | 12 (±16) | 13 (±12) | 49 | 37 | .04 | 0.2 |
| Thoracic kyphosis | 22 (±38) | 36 (±21) | 26 (±18) | 31 (±13) | 64 | 62 | .98 | 27 (±17) | 32 (±15) | 61 | 38 | .39 | 1.1 |
| Lumbar lordosis | 19 (±53) | 35 (±30) | 35 (±19) | 38 (±16) | 58 | 60 | .71 | 32 (±18) | 38 (±17) | 66 | 74 | .84 | 0.1 |
| Pelvic obliquity | 16 (±15) | 7 (±10) | 3 (±7) | 3 (±4) | 58 | 29 | .003 | 3 (±8) | 3 (±5) | 51 | 28 | .01 | 0.2 |
| Cobb | 59 ± 29 | 25 ± 20 | 57 | 27 ± 21 | 53 | 2 | |||||||
| Rotation | 26 ±19 | 14 ±13 | 40 | 13 ±13 | 43 | 0.3 | |||||||
| Thoracic kyphosis | 29 ± 31 | 29 ±16 | 63 | 30 ±16 | 49 | 1 | |||||||
| Lumbar lordosis | 27 ± 43 | 36 ±17 | 59 | 35 ±17 | 70 | 0.1 | |||||||
| Pelvic obliquity | 11 ±13 | 3 ± 6 | 42 | 3 ± 6 | 39 | 0.1 | |||||||
P-value of the difference in correction percentage between H1 and H2 adjusted for baseline differences between groups using multiple logistic regression.
Length of surgery, intensive care unit (ICU) and hospital stay, and relative bleeding for total study group and according to departments
| Operative outcome, mean | Total study group | H1 | H2 | Difference | 95% Confidence interval of the difference | |
|---|---|---|---|---|---|---|
| 535 | 498 | 572 | 74 | −145.8, −1.6 | .01 | |
| 1.6 | 1.7 | 1.5 | 0.2 | −0.15, 0.7 | .39 | |
| 11.6 | 12.5 | 10.8 | 1.7 | −1, 4.4 | .25 | |
| 73 | 80.3 | 66 | 14.3 | −2.2, 30.8 | .13 | |
| 57.9 | 66.5 | 50.4 | 16.1 | 8.1, 23.7 | <.001 |
P-value of the difference between H1 and H2 adjusted for baseline differences between groups using multiple logistic regression.
Complications for whole study group and according to departments
| Complications | H1 | H2 | |
|---|---|---|---|
| n (%) | n (%) | ||
| Urinary tract infection | 3 (4.7) | 3 (4.2) | |
| Allergic reaction | 1 (1.6) | 1 (1.4) | |
| Headache | 0 (0) | 1 (1.4) | |
| Superficial wound infection | 0 (0) | 3 (4.2) | |
| Pneumothorax | 0 (0) | 1 (1.4) | |
| Laryngospasm | 0 (0) | 1 (1.4) | |
| Lung atalectasis | 1 (1.6) | 1 (1.4) | |
| Anesthesia (other) | 0 (0) | 1 (1.4) | |
| Profuse vomiting | 0 (0) | 1 (1.4) | |
| Pressure sores | 2 (3.1) | 2 (2.8) | |
| Prominent iliac crest screw, without need for intervention | 2 (3.1) | 0 (0) | |
| Keloid scarring | 1 (1.6) | 1 (1.4) | |
| Pleuritis | 0 (0) | 1 (1.4) | |
| Aspiration | 1 (1.6) | 0 (0) | |
| Total minor complications (20.6 %) | 11 (16.9) | 17 (23.6) | .38 |
| Mortality | 0 (0) | 0 (0) | |
| Neurologic deterioration | 0 (0) | 0 (0) | |
| Decrease in functional capacity | 0 (0) | 0 (0) | |
| Part of drain left in pleural cavity during removal | 0 (0) | 1 (1.4) | |
| Deep infection | 2 (3.1) | 5 (6.9) | |
| Pneumonia | 1 (1.6) | 3 (4.2) | |
| CVK-induced septicemia | 0 (0) | 1 (1.4) | |
| Total | 3 (4.7) | 10 (13.9) | .06 |
| Prominent iliac crest screw, removal operation | 4 (6.3) | 1 (1.4) | |
| Other implant-related problems, removal operation | 1 (1.6) | 0 (0) | |
| Pseudarthrosis | 0 (0) | 1 (1.4) | |
| Progression outside fusion | 1 (1.6) | 0 (0) | |
| Total | 6 (9.4) | 2 (2.8) | .17 |
| Total major complications (15.4%) | 9 (14.1 ) | 12 (16.7) | .48 |
| All infections( within major and minor complications) | 6 (9.4) | 16 (22.2) | .04 |
P-value calculated adjusted for the baseline data differences (gender, diagnosis of MMC, wheelchair bound, and neurosurgery performed).
Events not related to surgical procedures or implants.